• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可生物降解聚合物微球作为玻璃体中的药物递送系统。

Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.

作者信息

Moritera T, Ogura Y, Honda Y, Wada R, Hyon S H, Ikada Y

机构信息

Department of Ophthalmology, Faculty of Medicine, Kyoto University, Japan.

出版信息

Invest Ophthalmol Vis Sci. 1991 May;32(6):1785-90.

PMID:2032801
Abstract

Microspheres of biodegradable polymers were evaluated as a potential controlled-release drug-delivery system in the vitreous. The microspheres were prepared with polymers of poly(lactic acid) or copolymers of glycolic acid and lactic acid. The release of 5-fluorouracil (5-FU) from the microspheres was studied in vitro. Poly(lactic acid) microspheres released 70-85% of total 5-FU over 7 days. Microspheres of polymers with a smaller molecular weight released the drug more rapidly. Copolymer microspheres released 98% of 5-FU over 2 days. The rate of drug release was controllable by changing the molecular weight of the polymers or using a matrix of copolymer. The intravitreal kinetics of the microspheres were studied in ten rabbits in vivo. A suspension of microspheres was injected into the vitreous cavity of five normal eyes and five vitrectomized eyes. By 48 +/- 5.2 days after injection, the microspheres disappeared from the vitreous cavity in the five normal eyes. Clearance from the vitreous cavity was accelerated in the five rabbits that underwent vitrectomy (14 +/- 2.4 days; P less than 0.001). No difference was found in the b waves of electroretinograms before and after injection of the microspheres. The histologic study showed no abnormal findings as a result of the injection. These results suggested that microspheres of biodegradable polymers may be a potential delivery system for the controlled release of drugs in the vitreous.

摘要

可生物降解聚合物微球被评估为一种潜在的玻璃体内控释给药系统。这些微球由聚乳酸聚合物或乙醇酸与乳酸的共聚物制备而成。对微球中5-氟尿嘧啶(5-FU)的体外释放情况进行了研究。聚乳酸微球在7天内释放了总量70-85%的5-FU。分子量较小的聚合物微球释放药物的速度更快。共聚物微球在2天内释放了98%的5-FU。通过改变聚合物的分子量或使用共聚物基质,药物释放速率是可控的。在10只兔子体内研究了微球的玻璃体内动力学。将微球悬浮液注入5只正常眼和5只玻璃体切除眼的玻璃体腔。注射后48±5.2天,5只正常眼中的微球从玻璃体腔消失。在接受玻璃体切除术的5只兔子中,玻璃体腔清除加速(14±2.4天;P<0.001)。注射微球前后视网膜电图的b波未发现差异。组织学研究显示注射后无异常发现。这些结果表明,可生物降解聚合物微球可能是一种在玻璃体内控制药物释放的潜在给药系统。

相似文献

1
Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.可生物降解聚合物微球作为玻璃体中的药物递送系统。
Invest Ophthalmol Vis Sci. 1991 May;32(6):1785-90.
2
[Intravitreal drug delivery by microspheres of biodegradable polymers].[可生物降解聚合物微球的玻璃体内药物递送]
Nippon Ganka Gakkai Zasshi. 1990 May;94(5):508-13.
3
Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres.玻璃体内可生物降解聚(D,L-丙交酯-乙交酯)酸微球的生物降解及组织反应
Curr Eye Res. 1995 Sep;14(9):761-8. doi: 10.3109/02713689508995797.
4
Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.在增生性玻璃体视网膜病变中,从可生物降解聚合物微球持续释放视黄酸。
Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2743-51.
5
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.玻璃体内注射载有地塞米松的聚乳酸-乙醇酸共聚物(PLGA)微球对内毒素诱导性葡萄膜炎的下调作用
Exp Eye Res. 2009 Aug;89(2):238-45. doi: 10.1016/j.exer.2009.03.012. Epub 2009 Mar 31.
6
Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates.从灵长类动物玻璃体中清除包裹微球的5-氟尿嘧啶和阿糖胞苷。
Int Ophthalmol. 1992 Mar;16(2):109-13. doi: 10.1007/BF00918942.
7
Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.兔玻璃体内血管内皮生长因子持续释放的定量磁共振成像研究
Invest Ophthalmol Vis Sci. 2000 May;41(6):1561-9.
8
Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus.接种人巨细胞病毒的兔眼中的载更昔洛韦聚合物微球。
Invest Ophthalmol Vis Sci. 1997 Mar;38(3):665-75.
9
Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.用于治疗葡萄膜炎的环孢素微球:体外表征及体内药代动力学研究
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3983-8. doi: 10.1167/iovs.05-1373.
10
Novel biodegradable polymers as gene carriers.新型可生物降解聚合物作为基因载体。
Macromol Biosci. 2004 Dec 15;4(12):1113-7. doi: 10.1002/mabi.200400125.

引用本文的文献

1
Review: Neuroprotective Nanocarriers in Glaucoma.综述:青光眼的神经保护纳米载体
Pharmaceuticals (Basel). 2024 Sep 10;17(9):1190. doi: 10.3390/ph17091190.
2
Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball.可生物降解微球崭露头角:一种有望用于将药物递送至眼球后段的生物材料。
Mater Today Bio. 2024 Jun 13;27:101126. doi: 10.1016/j.mtbio.2024.101126. eCollection 2024 Aug.
3
Advances in ophthalmic therapeutic delivery: A comprehensive overview of present and future directions.
眼科治疗药物传递的新进展:当前和未来方向的全面综述。
Surv Ophthalmol. 2024 Nov-Dec;69(6):967-983. doi: 10.1016/j.survophthal.2024.07.002. Epub 2024 Jul 8.
4
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds.眼部视网膜病变的给药系统:玻璃体内水凝胶作为缓释支架的光明未来。
Pharmaceutics. 2023 May 12;15(5):1484. doi: 10.3390/pharmaceutics15051484.
5
Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress.用于治疗青光眼的眼内纳微尺度药物输送系统:设计策略和最新进展。
J Nanobiotechnology. 2023 Mar 10;21(1):84. doi: 10.1186/s12951-023-01838-x.
6
Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid).基于聚(乳酸-共-乙醇酸)的纳米沉淀药物递送系统释放动力学模型的比较统计分析。
PLoS One. 2022 Mar 10;17(3):e0264825. doi: 10.1371/journal.pone.0264825. eCollection 2022.
7
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices.用于年龄相关性黄斑变性的生物技术和基于生物材料的治疗策略。第一部分:基于生物材料的药物递送装置。
Front Bioeng Biotechnol. 2020 Nov 3;8:549089. doi: 10.3389/fbioe.2020.549089. eCollection 2020.
8
Advances in ocular drug delivery systems.眼部药物传递系统的新进展。
Eye (Lond). 2020 Aug;34(8):1371-1379. doi: 10.1038/s41433-020-0809-0. Epub 2020 Feb 18.
9
The humanin peptide mediates ELP nanoassembly and protects human retinal pigment epithelial cells from oxidative stress.人源素肽介导 ELP 纳米组装并保护人视网膜色素上皮细胞免受氧化应激。
Nanomedicine. 2020 Feb;24:102111. doi: 10.1016/j.nano.2019.102111. Epub 2019 Oct 23.
10
Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection.载他克莫司纳米粒的制备及其对角膜移植排斥反应抑制作用的研究。
Drug Deliv. 2019 Dec;26(1):290-299. doi: 10.1080/10717544.2019.1582728.